ROIV
Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare
Roivant Sciences Ltd annual/quarterly total liabilities history from 2021 to 2026. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Roivant Sciences Ltd total liabilities for the quarter ending March 31, 2026 were 416.3M, a 66.68% increase year-over-year.
- Roivant Sciences Ltd total liabilities for 2026 were 416.3M, a 66.68% increase from 2025.
- Roivant Sciences Ltd total liabilities for 2025 were 249.7M, a 67.73% decrease from 2024.
- Roivant Sciences Ltd total liabilities for 2024 were 774.0M, a 1.03% decrease from 2023.
- Roivant Sciences Ltd total liabilities for 2023 were 782.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Roivant Sciences Ltd Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2026 | $416 |
| 2025 | $250 |
| 2024 | $774 |
| 2023 | $782 |
| 2022 | $524 |
| 2021 | $528 |
| Roivant Sciences Ltd Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2026-03-31 | $416 |
| 2025-03-31 | $250 |
| 2024-03-31 | $774 |
| 2023-03-31 | $782 |
| 2022-03-31 | $524 |
| 2021-03-31 | $528 |
Roivant Sciences Ltd Total Liabilities — FAQ
Roivant Sciences Ltd (ROIV) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ROIV's total liabilities history?
The chart and table above show Roivant Sciences Ltd's total liabilities by year and by quarter, including the growth rate.